David Eisenstat

Professor

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Cancer Biology Cancer Biology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Eisenstat is a Professor at the University of Melbourne, Australia. His research primarily focuses on pediatric oncology, particularly in the treatment of low and high-grade gliomas, as well as the mechanisms underlying cancer responses to DNA damage. Recent publications highlight his commitment to improving care frameworks for children with cancer and addressing challenges in low- and middle-income countries.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Collaborators (5)

Jordan R Hansford

University of Melbourne

AUSTRALIA

View details

Misty Rayna Jenkins

Lab Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Margaret L. McNeely

University of Alberta

CANADA

View details

Paula Ospina

University of Alberta

CANADA

View details

Michael Sullivan

Honorary Professor of Paediatrics

University of Otago Christchurch

NEW ZEALAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Eisenstat

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

The 2021 WHO classification of tumors of the central nervous system: Responding to the challenge in low- and middle-income countries

Deciphering UBE4B phosphorylation dynamics: a key mechanism in p53 accumulation and cancer cell response to DNA damage

A paradigm shift in how we treat pediatric low-grade glioma-Targeting the molecular drivers

A paradigm shift in how we treat pediatric low-grade glioma—Targeting the molecular drivers

The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models

The Landscape of Pediatric High-Grade Gliomas: The Virtues and Pitfalls of Pre-Clinical Models

No Safe Harbors for Recurrent PFA Ependymoma: A Time for Change in Risk Assignment?

Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals’ Perceptions of Barriers to Care and a Framework for Action

A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma

HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma

Advancing Pediatric Oncology Rehabilitation: Survey Findings of Health Professionals' Perceptions of Barriers to Care and a Framework for Action

A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial ZFTA-fused ependymoma

Medical Assistance in Dying (MAiD) in brain cancer: Whose autonomy are we respecting?

Collaborators (5)

Jordan R Hansford

Misty Rayna Jenkins

Margaret L. McNeely

Paula Ospina

Michael Sullivan

Make your next move.